Adjuvant Treatments for Surgically Resected Non-Small Cell Lung Cancer Harboring EGFR Mutations: A Review.
Sign Up to like & getrecommendations! Published in 2023 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2023.0459
Abstract: Importance The use of adjuvant chemotherapy for stage IB-IIIA resected non-small cell lung cancer (NSCLC) has limited benefit for improving cure rates. The proportion of epidermal growth factor receptor (EGFR) alterations among patients with resected… read more here.
Keywords: lung cancer; non small; resected non; small cell ... See more keywords
The Prognostic Impact of Pericardial Fat Volumes in Resected Non-small Cell Lung Cancer
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-019-07703-2
Abstract: Background Pericardial fat (PF) has not been considered a prognostic biomarker for overall survival (OS) in lung cancer. This study was designed to elucidate the impact of PF on prognosis of resected non-small cell lung… read more here.
Keywords: pericardial fat; resected non; volume; lung cancer ... See more keywords
ASO Author Reflections: The Possibility of a New Prognostic Biomarker of Pericardial Fat Volumes in Resected Non-small Cell Lung Cancer
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-019-08004-4
Abstract: Visceral fat volume is considered an important biomarker for overall survival (OS) in cancer. For patients with upper gastrointestinal cancer, visceral fat in the abdomen is a favorable prognostic factor. However, the prognostic significance of… read more here.
Keywords: volume; pericardial fat; non small; cancer ... See more keywords